Your browser doesn't support javascript.
loading
Too complex to fail? Targeting fatty acid metabolism for cancer therapy.
Munir, Rimsha; Lisec, Jan; Swinnen, Johannes V; Zaidi, Nousheen.
Afiliación
  • Munir R; Cancer Biology Lab, Institute of Microbiology and Molecular Genetics, University of the Punjab, Lahore, Pakistan; Hormone Lab Lahore, Pakistan.
  • Lisec J; Bundesanstalt für Materialforschung und -prüfung (BAM), Department of Analytical Chemistry, Richard-Willstätter-Straße 11, 12489 Berlin, Germany.
  • Swinnen JV; Laboratory of Lipid Metabolism and Cancer, Department of Oncology, Faculty of Medicine, KU Leuven, Leuven, Belgium.
  • Zaidi N; Cancer Biology Lab, Institute of Microbiology and Molecular Genetics, University of the Punjab, Lahore, Pakistan; Cancer Research Center (CRC), University of the Punjab, Lahore, Pakistan. Electronic address: nosheen.mmg@pu.edu.pk.
Prog Lipid Res ; 85: 101143, 2022 01.
Article en En | MEDLINE | ID: mdl-34856213
ABSTRACT
Given the central role of fatty acids in cancer pathophysiology, the exploitation of fatty acid metabolism as a potential antineoplastic therapy has gained much attention. Several natural and synthetic compounds targeting fatty acid metabolism were hitherto identified, and their effectiveness against cancer cell proliferation and survival was determined. This review will discuss the most clinically viable inhibitors or drugs targeting various proteins or enzymes mapped on nine interconnected fatty acid metabolism-related processes. We will discuss the general significance of each of these processes and the effects of their inhibition on cancer cell progression. Moreover, their mechanisms of action, limitations, and future perspectives will be assessed.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Límite: Humans Idioma: En Revista: Prog Lipid Res Año: 2022 Tipo del documento: Article País de afiliación: Pakistán

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Límite: Humans Idioma: En Revista: Prog Lipid Res Año: 2022 Tipo del documento: Article País de afiliación: Pakistán